MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Stock Balance Sheet
NASDAQ:MLTX • KY61559X1045
Current stock price
18.64 USD
+1.71 (+10.1%)
At close:
18.65 USD
+0.01 (+0.05%)
After Hours:
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 8.04M | 1.34M | |||
| Cash Equivalents | N/A | 451.17M | 39.51M | N/A | N/A | |||
| Marketable Securities | N/A | 59.84M | 32.61M | N/A | N/A | |||
| Receivables | 26.00M | 1.06M | 4.18M | 1.43M | N/A | |||
| Other Current Assets | 450.00K | 2.10M | 210.00K | 170.00K | 283.06K | |||
| Total Current Assets | 474.00M | 514.17M | 76.51M | 9.64M | 1.62M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.64M | 3.95M | 330.00K | 50.00K | N/A | |||
| Investments And Advances | N/A | N/A | N/A | 115.04M | 115.01M | |||
| Other Non-Current Assets | N/A | 8.42M | N/A | N/A | N/A | |||
| Total Non-Current Assets | 4.00M | 12.37M | 330.00K | 40.00K | 115.01M | |||
| TOTAL ASSETS | 478.00M | 526.54M | 76.84M | 9.68M | 116.63M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 15.00M | 58.06K | |||
| Accrued Expenses | 13.00M | 8.13M | 7.41M | 4.52M | 67.12K | |||
| Accounts Payable | 8.77M | 1.46M | 140.00K | 1.43M | N/A | |||
| Other Current Liabilities | 220.00K | 372.80K | 120.00K | 140.00K | N/A | |||
| Total Current Liabilities | 22.00M | 9.97M | 7.67M | 21.09M | 125.18K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.08M | 3.08M | 410.00K | 240.00K | 4.03M | |||
| Total Non-Current Liabilities | 9.00M | 20.90M | 20.28M | 240.00K | 4.02M | |||
| TOTAL LIABILITIES | 31.00M | 30.86M | 27.95M | 21.33M | 4.15M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -236.00M | -116.66M | -80.65M | -53.64M | -90.84K | |||
| Additional Paid In Capital | 677.00M | 609.97M | 129.19M | 42.06M | 5.09M | |||
| Minority Interest | 6.57M | 17.82M | 19.87M | N/A | N/A | |||
| Common Shares | 10.00K | 6.30K | 10.00K | 110.00K | 107.48M | |||
| Treasury Stock | N/A | N/A | N/A | -10.00K | N/A | |||
| Other Shareholders' Equity | 5.00M | 2.36M | 350.00K | -170.00K | N/A | |||
| Shares Outstanding | 63.00M | 60.47M | 38.98M | 36.93M | 14.80M | |||
| Tangible Book Value per Share | N/A | 8.20 | 1.25 | -0.32 | 7.60 | |||
| Total Shareholders' Equity | 447.00M | 495.68M | 48.90M | -11.65M | 112.48M | |||
| TOTAL LIABILITIES AND EQUITY | 478.00M | 526.54M | 76.84M | 9.68M | 116.63M | |||
| Statistics | ||||||||
| Current Ratio | 21.55 | 51.59 | 9.98 | 0.46 | 12.93 | |||
| Return On Assets (ROA) | -24.88% | -6.84% | -65.03% | -554.13% | -0.08% | |||
| Return On Equity (ROE) | -26.61% | -7.26% | -102.19% | N/A | -0.08% | |||
All data in USD , ROIC based on taxRate of 0.21